Phillip Dennis

Phillip Dennis is a seasoned medical professional currently serving as Chief Medical Officer at I-Mab Biopharma since June 2024. Phillip has extensive experience in oncology, having held significant positions such as Vice President of Lung Cancer Strategy and Global Project Head at Sanofi and Vice President and Global Clinical Lead for Lung Cancer Strategy at AstraZeneca. Phillip's involvement in scientific advisory boards includes roles at PTEN Research and the Cancer Molecular Therapeutics Research Association. Academic contributions include a tenure as Professor of Oncology and Pharmacology at The Johns Hopkins University School of Medicine and a Senior Investigator at the NCI, NIH. Education credentials include an MD and PhD from New York Medicine Jobs and multiple BA degrees in Biology from the University of Virginia.